New Experimental Drug Shows Promise Against Pancreatic Cancer

A new experimental drug has reportedly doubled the average survival time for individuals with pancreatic cancer, extending it from six and a half months to 13 months. This development offers new hope in the fight against one of the deadliest forms of cancer.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

der-standardGerman93d ago

Neue Hoffnung im Kampf gegen eine der tödlichsten Krebsarten

Neues experimentelles Medikament verdoppelt die durchschnittliche Überlebensdauer von Menschen mit Bauchspeicheldrüsenkrebs von sechseinhalb auf 13 Monate

Read full article →

New Experimental Drug Shows Promise Against Pancreatic Cancer

Sources

Neue Hoffnung im Kampf gegen eine der tödlichsten Krebsarten

Related Stories

Singer Lionel Richie Discharged After Cardiac Evaluation

Study suggests widely used sweetener may have serious health risks

Ebola Death Toll Surpasses 3,000 in Democratic Republic of Congo

Teva Reports Positive Mid-Stage Trial Results for Celiac Disease Drug